Like other drugs, Amvuttra (vutrisiran) can cause side effects, such as difficulty breathing and low vitamin A levels. If you can’t tolerate side effects of Amvuttra, talk with your doctor.
Alnylam's lead candidate for ATTR-CM, Amvuttra (vutrisiran), has shown promising results in the HELIOS-B clinical trial. The top-line data demonstrated a significant reduction in mortality, with ...
Alnylam's lead candidate for ATTR-CM, Amvuttra (vutrisiran), has shown promising results in the HELIOS-B clinical trial. The top-line data demonstrated a significant reduction in mortality ...
The company is at an inflection point as its key asset, Amvuttra’s, will likely launch in ATTR-cardiomyopathy, which will drive the next leg of growth, the firm contends. It has a Buy rating on ...
Management has forecast top sales of $5 billion for brensocatib in NCFB alone. 4. Alnylam’s Amvuttra/vutrisiran (ATTR-CM) Alnylam’s key pipeline drug, Amvuttra (vutrisiran) has an FDA decision date of ...
TKMAXX has launched an enormous double sticker sale with huge discounts on big brands. Double yellow sticker season is upon us and one reseller is taking full advantage of the sales. George Ross ...
Surrounded by a retinue of MAGA-hatted men on Thursday night, Sticker Mule CEO Anthony Constantino stood outside Amsterdam City Hall in a fast-talking fury. In front of him was Zoning Board of ...